Isomorphic Labs
Isomorphic Labs and MSD Partner on AI-Driven Cancer Drug Discovery
Isomorphic Labs and MSD have agreed to collaborate on discovering small-molecule drug candidates for a strategically important cancer indication. The partnership…
BusinessIsomorphic Labs and MSD form AI drug discovery partnership
Isomorphic Labs and MSD have formed a research collaboration to discover small-molecule therapeutic candidates aimed at an oncology target of strategic importance. The…
BusinessIsomorphic Labs and MSD Enter Strategic Research Collaboration
Isomorphic Labs and MSD have entered a strategic research collaboration, according to a PR Newswire news release dated November 19, 2026. The supplied release text…
Top storyIsomorphic Labs announces $5 billion Series C funding round
Isomorphic Labs has announced a $5 billion Series C funding round, according to a PR Newswire release dated November 18, 2026. The announcement provides the size and…
Top storyIsomorphic Labs announces $5 billion Series C funding round
Isomorphic Labs has announced a $5 billion Series C financing round, according to a PR Newswire release dated November 18, 2026. The announcement identifies the size and…
Top storyIsomorphic Labs raises $5 billion to scale AI drug discovery
Isomorphic Labs has raised $5 billion in an oversubscribed Series C round to expand its AI drug design engine, develop therapeutic candidates and build infrastructure…